Brief: Star Combo Pharma Says FY Loss From Ordinary Activities Attributable $1.7 Mln
Aug 28 (Reuters) - Star Combo Pharma Ltd S66.AX :
* FY LOSS FROM ORDINARY ACTIVITIES ATTRIBUTABLE $1.7 MILLION
VERSUS LOSS OF $1.6 MILLION
* FY REVENUE FROM ORDINARY ACTIVITIES $21.6 MILLION, UP
98.1%
* EXPECT 2020 WILL DELIVER "STRONG" REVENUE GROWTH AND
EARNINGS
Source text https://bit.ly/2ZqPicN
Further company coverage: S66.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Star Combo Pharma
See all newsBrief: Star Combo Pharma Announces Insurance Claim Settlement Of A$5 Million
Brief: Star Combo Pharma Says Outlook For FY2025 Is Positive
Brief: Star Combo Pharma Says HY Operating Loss Attributable A$4.4 Million
Brief: Star Combo Pharma Posts Q1 Fy23 Revenue Of A$6.55M
Australia's Star Combo Pharma plunges to record low on fire incident